Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Nature Biotechnology | journal | 22.781 Q1 | 511 | 389 | 1033 | 9513 | 20920 | 422 | 16.74 | 24.46 | 33.74 | |
52 | Molecular Therapy - Oncolytics | journal | 1.339 Q1 | 42 | 154 | 420 | 9805 | 2379 | 420 | 5.60 | 63.67 | 40.14 | |
53 | Stem Cells | journal | 1.339 Q1 | 253 | 94 | 431 | 5885 | 2123 | 411 | 4.82 | 62.61 | 42.53 | |
54 | Pharmaceutical Biology | journal | 0.646 Q3 | 88 | 216 | 409 | 9968 | 1818 | 408 | 3.98 | 46.15 | 43.81 | |
55 | Current Drug Targets | journal | 0.621 Q3 | 119 | 110 | 419 | 12345 | 1457 | 403 | 3.15 | 112.23 | 37.65 | |
56 | Mitochondrion | journal | 1.188 Q2 | 109 | 76 | 410 | 6573 | 1791 | 403 | 4.31 | 86.49 | 41.33 | |
57 | Journal of Molecular Diagnostics | journal | 1.245 Q2 | 111 | 118 | 406 | 4280 | 1592 | 392 | 3.90 | 36.27 | 49.77 | |
58 | Human Gene Therapy | journal | 1.045 Q2 | 159 | 132 | 446 | 5597 | 1486 | 389 | 2.92 | 42.40 | 44.17 | |
59 | Journal of Asian Natural Products Research | journal | 0.328 Q4 | 51 | 128 | 407 | 2887 | 738 | 385 | 1.84 | 22.55 | 40.83 | |
60 | Journal of Molecular Medicine | journal | 1.276 Q1 | 157 | 124 | 398 | 9755 | 1957 | 384 | 4.72 | 78.67 | 47.00 | |
61 | Planta Medica | journal | 0.521 Q3 | 135 | 168 | 388 | 8149 | 1226 | 376 | 2.90 | 48.51 | 46.81 | |
62 | Genome Medicine | journal | 4.851 Q1 | 123 | 141 | 381 | 10038 | 4632 | 370 | 11.63 | 71.19 | 43.95 | |
63 | Bioinspiration and Biomimetics | journal | 0.809 Q2 | 87 | 131 | 363 | 7356 | 1280 | 361 | 3.37 | 56.15 | 24.79 | |
64 | EMBO Molecular Medicine | journal | 3.932 Q1 | 142 | 126 | 422 | 7785 | 4201 | 356 | 9.50 | 61.79 | 46.64 | |
65 | Biotechnology and Applied Biochemistry | journal | 0.467 Q3 | 81 | 240 | 359 | 14045 | 1113 | 354 | 3.01 | 58.52 | 42.63 | |
66 | Cancer Biology and Therapy | journal | 0.996 Q2 | 130 | 64 | 356 | 2710 | 1604 | 354 | 3.28 | 42.34 | 38.20 | |
67 | Journal of Pharmacological Sciences | journal | 0.801 Q2 | 101 | 108 | 346 | 4695 | 1254 | 346 | 3.55 | 43.47 | 30.14 | |
68 | Molecular Pharmacology | journal | 1.061 Q2 | 210 | 68 | 347 | 4271 | 1269 | 343 | 3.45 | 62.81 | 35.95 | |
69 | Pharmacogenomics | journal | 0.435 Q3 | 100 | 98 | 356 | 4115 | 821 | 342 | 2.02 | 41.99 | 42.41 | |
70 | Current Pharmaceutical Analysis | journal | 0.178 Q4 | 27 | 88 | 340 | 4225 | 222 | 335 | 0.64 | 48.01 | 44.69 | |
71 | Molecular Medicine | journal | 1.245 Q1 | 133 | 162 | 333 | 9799 | 1921 | 331 | 5.46 | 60.49 | 41.93 | |
72 | Letters in Drug Design and Discovery | journal | 0.192 Q4 | 37 | 89 | 355 | 4304 | 346 | 329 | 1.00 | 48.36 | 36.31 | |
73 | Bulletin of Siberian Medicine | journal | 0.147 Q4 | 9 | 94 | 322 | 3269 | 136 | 322 | 0.34 | 34.78 | 64.53 | |
74 | Expert Review of Vaccines | journal | 1.346 Q1 | 105 | 178 | 333 | 13191 | 1886 | 316 | 6.10 | 74.11 | 44.05 | |
75 | Trends in Molecular Medicine | journal | 2.974 Q1 | 204 | 113 | 335 | 8167 | 3327 | 314 | 9.22 | 72.27 | 35.49 | |
76 | Infectious Disorders - Drug Targets | journal | 0.298 Q4 | 61 | 100 | 328 | 4928 | 482 | 311 | 1.40 | 49.28 | 43.11 | |
77 | Expert Review of Molecular Diagnostics | journal | 0.910 Q2 | 89 | 100 | 357 | 7967 | 1565 | 299 | 4.53 | 79.67 | 44.09 | |
78 | SLAS Discovery | journal | 1.042 Q2 | 33 | 56 | 318 | 1177 | 961 | 298 | 3.04 | 21.02 | 38.21 | |
79 | Journal of Cardiovascular Translational Research | journal | 0.853 Q2 | 60 | 131 | 300 | 5557 | 1068 | 279 | 3.51 | 42.42 | 37.38 | |
80 | Archives of Pharmacal Research | journal | 1.163 Q2 | 105 | 57 | 279 | 5524 | 1740 | 278 | 6.67 | 96.91 | 45.72 | |
81 | Virologica Sinica | journal | 0.942 Q2 | 47 | 118 | 362 | 4602 | 1442 | 273 | 4.26 | 39.00 | 42.06 | |
82 | Journal of Gene Medicine | journal | 0.657 Q3 | 100 | 57 | 273 | 2577 | 943 | 268 | 3.44 | 45.21 | 40.68 | |
83 | Journal of Natural Medicines | journal | 0.581 Q3 | 59 | 86 | 295 | 3002 | 980 | 268 | 3.43 | 34.91 | 36.43 | |
84 | Expert Opinion on Therapeutic Targets | journal | 1.581 Q1 | 106 | 83 | 282 | 10108 | 1611 | 260 | 5.19 | 121.78 | 37.77 | |
85 | Turkish Journal of Pharmaceutical Sciences | journal | 0.303 Q4 | 22 | 89 | 267 | 3368 | 486 | 257 | 1.78 | 37.84 | 48.89 | |
86 | Phytochemical Analysis | journal | 0.533 Q3 | 83 | 103 | 258 | 4264 | 952 | 256 | 3.42 | 41.40 | 51.12 | |
87 | EXCLI Journal | journal | 0.720 Q3 | 55 | 101 | 355 | 5713 | 1138 | 255 | 3.47 | 56.56 | 40.22 | |
88 | Pharmacogenomics and Personalized Medicine | journal | 0.469 Q3 | 37 | 82 | 255 | 3539 | 553 | 253 | 1.90 | 43.16 | 44.67 | |
89 | Future Cardiology | journal | 0.399 Q4 | 43 | 101 | 267 | 3397 | 402 | 249 | 1.50 | 33.63 | 31.29 | |
90 | Medicinal Research Reviews | journal | 2.748 Q1 | 150 | 63 | 250 | 12505 | 3621 | 245 | 14.08 | 198.49 | 44.66 | |
91 | Molecular Pain | journal | 0.824 Q2 | 96 | 55 | 239 | 2834 | 838 | 238 | 3.30 | 51.53 | 41.21 | |
92 | BioFactors | journal | 1.139 Q2 | 113 | 86 | 235 | 6718 | 1522 | 231 | 6.65 | 78.12 | 42.20 | |
93 | Cellular oncology (Dordrecht) | journal | 1.408 Q1 | 58 | 82 | 229 | 6314 | 1399 | 226 | 6.27 | 77.00 | 44.43 | |
94 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.254 Q4 | 53 | 81 | 224 | 2783 | 342 | 224 | 1.47 | 34.36 | 38.72 | |
95 | Cancer Gene Therapy | journal | 1.384 Q1 | 99 | 178 | 231 | 8770 | 1418 | 222 | 6.38 | 49.27 | 40.49 | |
96 | Molecular and Cellular Oncology | journal | 0.436 Q3 | 37 | 17 | 312 | 392 | 347 | 220 | 1.05 | 23.06 | 54.55 | |
97 | Current Molecular Medicine | journal | 0.490 Q3 | 117 | 81 | 231 | 6991 | 534 | 219 | 2.53 | 86.31 | 42.06 | |
98 | Viral Immunology | journal | 0.559 Q3 | 70 | 86 | 261 | 3685 | 483 | 218 | 1.77 | 42.85 | 47.29 | |
99 | Pharmacogenomics Journal | journal | 0.621 Q3 | 95 | 38 | 215 | 1655 | 656 | 212 | 2.93 | 43.55 | 37.08 | |
100 | Biomimetics | journal | 0.609 Q3 | 32 | 248 | 215 | 13944 | 1030 | 210 | 5.13 | 56.23 | 35.33 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®